AIM: To evaluate disease-specific quality of life (QOL) in liver cirrhosis patients and to compare it with those of a healthy population. Also an important objective was to assess whether QOL in liver cirrhosis patients differs by age and gender, by type and severity of disease. METHODS: The case group of 131 liver cirrhosis patients was selected. The control group of 262 was enrolled from a healthy population according to the scheme of case-control study. Clinical, demographic, laboratory data were collected. QOL was measured with a specific chronic liver disease questionnaire (CLDQ), which was translated and validated in Lithuanian. QOL scores were compared between groups by age, gender, type and severity of disease. Cronbach's alpha statistics calculation was used for evaluation of internal consistency reliability. Student's t test or ANOVA were used for evaluation hypothesis about probability equation. RESULTS: QOL was significantly lower in liver cirrhosis patients than in healthy population (59.5 +/- 18.3 vs 85.3 +/- 12.3, P < 0.001). The significant QOL differences between case and control groups were observed in domains of worry and abdominal symptoms, the smaller differences-in emotional functions and systematic symptom domains. Significantly worse QOL was in observed patients with increased clinical severity of the disease measured by Child-Pugh class. Age, gender and etiology of disease had an insignificant effect on QOL in cirrhotic patients. CONCLUSION: QOL was significantly impaired in all CLDQ domains in liver cirrhosis patients. Increase in severity of disease was the major factor associated with poorer QOL.
AIM: To evaluate disease-specific quality of life (QOL) in liver cirrhosispatients and to compare it with those of a healthy population. Also an important objective was to assess whether QOL in liver cirrhosispatients differs by age and gender, by type and severity of disease. METHODS: The case group of 131 liver cirrhosispatients was selected. The control group of 262 was enrolled from a healthy population according to the scheme of case-control study. Clinical, demographic, laboratory data were collected. QOL was measured with a specific chronic liver disease questionnaire (CLDQ), which was translated and validated in Lithuanian. QOL scores were compared between groups by age, gender, type and severity of disease. Cronbach's alpha statistics calculation was used for evaluation of internal consistency reliability. Student's t test or ANOVA were used for evaluation hypothesis about probability equation. RESULTS: QOL was significantly lower in liver cirrhosispatients than in healthy population (59.5 +/- 18.3 vs 85.3 +/- 12.3, P < 0.001). The significant QOL differences between case and control groups were observed in domains of worry and abdominal symptoms, the smaller differences-in emotional functions and systematic symptom domains. Significantly worse QOL was in observed patients with increased clinical severity of the disease measured by Child-Pugh class. Age, gender and etiology of disease had an insignificant effect on QOL in cirrhotic patients. CONCLUSION: QOL was significantly impaired in all CLDQ domains in liver cirrhosispatients. Increase in severity of disease was the major factor associated with poorer QOL.
Authors: I M Gralnek; R D Hays; A Kilbourne; H R Rosen; E B Keeffe; L Artinian; S Kim; D Lazarovici; D M Jensen; R W Busuttil; P Martin Journal: Am J Gastroenterol Date: 2000-12 Impact factor: 10.864
Authors: G Marchesini; G Bianchi; P Amodio; F Salerno; M Merli; C Panella; C Loguercio; G Apolone; M Niero; R Abbiati Journal: Gastroenterology Date: 2001-01 Impact factor: 22.682
Authors: Chang Keun Park; Soo Young Park; Eun Soo Kim; Jin Hyung Park; Dong Woo Hyun; Young Mi Yun; Chang Min Jo; Won Young Tak; Young Oh Kweon; Sung Kook Kim; Yong Hwan Choi; Shin Goo Park Journal: Taehan Kan Hakhoe Chi Date: 2003-09
Authors: Samer El-Dika; Gordon H Guyatt; David Armstrong; Alessio Degl'innocenti; Ingela Wiklund; Carlo A Fallone; Lisa Tanser; Sander Veldhuyzen van Zanten; Diane Heels-Ansdell; Peter Wahlqvist; Naoki Chiba; Alan N Barkun; Peggy Austin; Holger J Schünemann Journal: BMC Gastroenterol Date: 2005-07-10 Impact factor: 3.067
Authors: Samantha Mucci; Vanessa de Albuquerque Citero; Adriano Miziara Gonzalez; Luciana Geocze; Stephan Geocze; Gaspar de Jesus Lopes Filho; Mario Alfredo De Marco; Edison Roberto Parise; Luiz Antonio Nogueira Martins Journal: Qual Life Res Date: 2012-03-03 Impact factor: 4.147
Authors: Hilda Mahmoudi; Peyman Jafari; Mahvash Alizadeh-Naini; Siyavash Gholami; Seyed Ali Malek-Hosseini; Sina Ghaffaripour Journal: Qual Life Res Date: 2011-11-13 Impact factor: 4.147
Authors: Dusan Dj Popovic; Nada V Kovacevic; Darija B Kisic Tepavcevic; Goran Z Trajkovic; Tamara M Alempijevic; Milan M Spuran; Miodrag N Krstic; Rada S Jesic; Zobair M Younossi; Tatjana D Pekmezovic Journal: World J Gastroenterol Date: 2013-08-14 Impact factor: 5.742
Authors: Kelly L Hayward; Patricia C Valery; Jennifer H Martin; Antara Karmakar; Preya J Patel; Leigh U Horsfall; Caroline J Tallis; Katherine A Stuart; Penny L Wright; David D Smith; Katharine M Irvine; Elizabeth E Powell; W Neil Cottrell Journal: World J Gastroenterol Date: 2017-10-28 Impact factor: 5.742